Publications by authors named "Catherine Emmanuel"

12Publications

Response rates to second-line platinum-based therapy in ovarian cancer patients challenge the clinical definition of platinum resistance.

Gynecol Oncol 2018 08 26;150(2):239-246. Epub 2018 May 26.

Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Department of Gynaecological Oncology, Westmead Hospital, Westmead, New South Wales, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2018.05.020DOI Listing
August 2018

Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver.

Clin Cancer Res 2014 Dec 14;20(24):6618-30. Epub 2014 Oct 14.

Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia. Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia. University of Sydney, Westmead Hospital, Sydney, New South Wales, Australia. Westmead Institute for Cancer Research, Westmead Millennium Institute, Westmead Hospital, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-1292DOI Listing
December 2014

ABCA transporter gene expression and poor outcome in epithelial ovarian cancer.

J Natl Cancer Inst 2014 Jul 23;106(7). Epub 2014 Jun 23.

Affiliations of authors: Children's Cancer Institute Australia, Randwick, Australia (ELH, AJR, RTW, CF, MDN, MH, MJH); Department of Gynaecological Oncology and Westmead Institute for Cancer Research (BG, CE, AOCSG, AdF), Crown Princess Mary Cancer Centre and Westmead Institute for Cancer Research (PH) University of Sydney at the Westmead Millennium Institute, Westmead Hospital, Sydney, Australia; Queensland Institute of Medical Research, Brisbane, Australia (YL, JB, SEJ, XC, AOCSG, GC-T, SM); Peter MacCallum Cancer Centre, Melbourne, Australia (JG, AOCSG, DDB); Vesalius Research Center, VIB, Leuven, Belgium (DL); Department of Oncology, University of Leuven and University Hospitals Leuven, Leuven, Belgium (ED, SL, IV); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (BK, JL, SO, CW); Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany (PF, MWB, AH); University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA (PF); Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan (ABE, KM, SH); Department of Gynecology (TN), and Department of Pathology and Molecular Diagnostics (YY), Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan; Department of Obstetrics and Gynecology (TP, YB), and Knight Cancer Institute (TP, YB), Oregon Health & Science University, Portland, OR; Institute of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Erlangen, Germany (FH); Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany (FH); De

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju149DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110473PMC
July 2014

Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer.

Sci Rep 2014 May 9;4:4669. Epub 2014 May 9.

1] Department of Gynaecological Oncology, Westmead Hospital [2] Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Sydney, Australia [3] Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, Australia [4].

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep04669DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015028PMC
May 2014

TNF-α and TGF-β synergistically stimulate elongation of human endothelial cells without transdifferentiation to smooth muscle cell phenotype.

Cytokine 2013 Jan 30;61(1):38-40. Epub 2012 Oct 30.

Cellular and Molecular Pathology Research Unit, Department Oral Pathology, Westmead Centre for Oral Health, Westmead Hospital, The University of Sydney, NSW 2145 Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cyto.2012.09.017DOI Listing
January 2013

Ultrastructural changes in endothelium during apoptosis indicate low microembolic potential.

J Vasc Res 2005 Sep-Oct;42(5):377-87. Epub 2005 Jul 25.

Cellular and Molecular Pathology Research Unit, Department of Oral Pathology and Oral Medicine, University of Sydney, Westmead Centre for Oral Health S, Westmead, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000087213DOI Listing
October 2005

Synergistic induction of apoptosis in human endothelial cells by tumour necrosis factor-alpha and transforming growth factor-beta.

Cytokine 2002 Jun;18(5):237-41

Cellular and Molecular Pathology Research Unit, Department of Oral Medicine and Oral Pathology, University of Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1006/cyto.2002.1042DOI Listing
June 2002